Related Experiment Video

Updated: Sep 21, 2025

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
11:47

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells

Published on: April 3, 2019

9.3K

ATP-gated P2X7 receptor as a potential target for prostate cancer

Cuicui Qiao1, Yiqing Tang1, Qianqian Li1

  • 1School of Laboratory Medicine, Weifang Medical University, Weifang, 261053, Shandong, China.

Human Cell
|June 3, 2022
PubMed

Insights

The P2X7 receptor is crucial in prostate cancer development and progression. Targeting this receptor may offer a new therapeutic strategy for prostate cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Prostate cancer is a leading cause of male cancer death.
  • The P2X7 receptor, an ATP-gated ion channel found in immune cells, plays a role in tumorigenesis.
  • Abnormal P2X7 receptor expression is observed in prostate cancer.

Purpose of the Study:

  • To investigate the role of the P2X7 receptor in prostate cancer.
  • To explore the P2X7 receptor as a potential early biomarker for prostate cancer.
  • To evaluate the P2X7 receptor as a therapeutic target for prostate cancer.

Main Methods:

  • Review of existing studies on P2X7 receptor expression and function in prostate cancer.
  • Analysis of the relationship between P2X7 receptor levels and prostate-specific antigen.
  • Examination of the P2X7 receptor's influence on epithelial-mesenchymal transition and related signaling pathways (PI3K/AKT, ERK1/2).

Main Results:

  • P2X7 receptor expression is abnormal in prostate cancer and correlates with prostate-specific antigen levels.
  • The P2X7 receptor is essential for prostate cancer occurrence and development.
  • P2X7 receptor influences prostate cancer cell invasion and metastasis via epithelial-mesenchymal transition and signaling pathways.

Conclusions:

  • The P2X7 receptor may serve as an early biomarker for prostate cancer.
  • The P2X7 receptor is integral to prostate cancer progression.
  • Targeting the P2X7 receptor presents a promising therapeutic avenue for prostate cancer.
Keywords:
ATPInvasionMetastasisP2X7 receptorProstate cancer

More Related Videos

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels16:36

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels

Published on: May 18, 2009

14.8K
Mechanical Stimulation-induced Calcium Wave Propagation in Cell Monolayers: The Example of Bovine Corneal Endothelial Cells10:46

Mechanical Stimulation-induced Calcium Wave Propagation in Cell Monolayers: The Example of Bovine Corneal Endothelial Cells

Published on: July 16, 2013

16.4K

Related Concept Videos

ATP Driven Pumps II: P-type Pumps01:34

ATP Driven Pumps II: P-type Pumps

The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
5.2K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.3K
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
8.6K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.7K